Oestrogen downregulates BACE protein in human cell culture: What does this teach us about Alzheimer's disease?

Neurodegenerative Diseases

Volumn 8, Issue 3, 2011, Pages 153-154

  Bernstein, Hans Gert ^a   Lendeckel, Uwe ^b   Steiner, Johann ^a   Bogerts, Bernhard ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SECRETASE; ESTROGEN;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; ENZYME ACTIVITY; GENE EXPRESSION; GLIA CELL; HORMONE RESPONSE; HUMAN; HUMAN CELL CULTURE; NERVE CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; CELLS, CULTURED; DOWN-REGULATION; ESTROGENS; HUMANS; NEUROGLIA; NEURONS;

EID: 79953294911     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000320087     Document Type: Note

References (9)

1. Csöregh Nord L, Sundqvist J, Andersson E, Fried G: Analysis of oestrogen regulation ofα-β-andγ-secretase gene and protein expression in cultured human neuronal and glial cells. Neurodegenerative Dis 2010;7: 349-.364.
2. Zhao L, Yao J, Mao Z, Chen S, Wang Y, Brinton RD: 17β-estradiol regulates insulin-degrading enzyme via ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol Aging 2010, E-pub ahead of print.
3. Amtul Z, Wang L, Westaway D, Rozmahel RF: Neuroprotective mechanism conferred by 17β-estradiol biochemical basis of Alzheimer's disease. Neuroscience 2010; 169: 781-.786.
4. Liang K, Yang L, Yin C, Xiao Z, Zhang J, Liu Y, Huang J: Estrogen stimulates degradation ofβ-amyloid peptide by up-regulating neprilysin. J Biol Chem 2010; 8: 935-.942.
5. Hook V, Toneff T, Bogyo M, Greenbaum D, Medzihradszky KF, Neveau J, Lane W, Hook G, Reisine T: Inhibition of cathepsin B reducesβ-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidateβ- secretase of Alzheimer's disease. Biol Chem 2005; 386: 931-.940. (Pubitemid 41448149)
6. Hook VY, Kindy M, Hook G: Inhibitors of cathepsin B improve memory and reduceβ- amyloid in transgenic Alzheimer disease mice expressing wild-type, but not Swedish mutant,β-secretase site of the amyloid precursor protein. J Biol Chem 2008; 283: 7745-.7753.
7. Hook V, Hook G, Kindy M: Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduceβ-amyloid related to Alzheimer's disease. Biol Chem 2010; 391:861-.872.
8. Radzikowska E, Janicki K, Maciejewski R, Maddej B: Estrogen-dependent activity of kidney lysosomal proteolytic enzymes. Ann Univ Mariae Curie Sklodowska Med 2001; 56: 213-.219.
9. Balan KV, Hollis VW, Eckberg WR, Ayorinde F, Karkera JD, Wyche JH, Anderson WA: Cathepsin B and complement C3 are major comigrants in the estrogen-induced peroxidase fraction of rat uterine fluid. J Submicrosc Cytol Pathol 2001; 33: 221-.230. (Pubitemid 33759996)